Tag:
Fresenius Kabi
Latest Headlines
Latest Headlines
FDA seeks 3 years of heparin test results from APP Pharmaceuticals
APP Pharmaceuticals ( $APPX ) has had its production of heparin called into question in an FDA warning letter and has been ordered to present three years worth of out-of-specification results for...
Analysts ponder takeover of ailing Hospira
Bloomberg speculates generics-maker Hospira ( $HSP ), currently limping with GMP remediation efforts across multiple manufacturing sites, is becoming attractive as a takeover target to other generics
IMS advises risk-based warning system for drug shortages
The IMS Institute for Healthcare Informatics has weighed in on the drug shortages issue, finding that more than 100 suppliers are involved, in contrast to many reports that generally attribute the
APP taps parent Fresenius' facilities to boost propofol supply
APP Pharmaceuticals ( $APPX ) has boosted production of propofol , long on the FDA's list of drugs in short supply, and reports its two versions of the drug are "readily available." The drugmaker, a
Pill mix-up leads to cancer drug recall
Cross contamination has led to the recall of a cancer drug shipped to the U.S. The drug is Fresenius Kabi's anastrozole, and it was made by the German company's subsidiary in India, Fresenius Kabi
